Zoledronate increases bone mineral density in non-ambulant children with cerebral palsy: A randomized, controlled trial. Supplemental material.

Name: Zoledronate increases bone mineral density in non-ambulant children with cerebral palsy: A randomized, controlled trial. Supplemental material.
Creator: Jakob Granild-Jensen
Published: 2023-05-16T15:34:46.007Z
Keywords: Pediatric Endocrinology, Osteoporosis, Bone Metabolism, Patient with Cerebral Palsy, Bisphosphonate

Granild-Jensen, Jakob

doi:10.17632/m87sszn9rk.1

Zoledronate increases bone mineral density in non-ambulant children with cerebral palsy: A randomized, controlled trial. Supplemental material.

Published: 16 May 2023| Version 1 | DOI: 10.17632/m87sszn9rk.1

Contributor:

Jakob Granild-Jensen

Description

Supplemental Material

Files

Steps to reproduce

See EU Clinical Trials Register, EudraCT Number: 2014-002118-21

Institutions

Aarhus Universitet Health, Regionshospitalet Randers

Zoledronate increases bone mineral density in non-ambulant children with cerebral palsy: A randomized, controlled trial. Supplemental material.

Description

Files

Steps to reproduce

Institutions

Categories

License